טוען...
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Chimeric antigen receptor (CAR) is a recombinant immunoreceptor combining an antibody-derived targeting fragment with signaling domains capable of activating cells, which endows T cells with the ability to recognize tumor-associated surface antigens independent of the expression of major histocompat...
שמור ב:
| הוצא לאור ב: | Protein Cell |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Higher Education Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5712290/ https://ncbi.nlm.nih.gov/pubmed/28466386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13238-017-0400-z |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|